Medline Inc. 预计,其Medline品牌床退出市场所涉及的相关成本在2026年和2027年合计最高可达2.2亿美元,该笔费用将不计入调整后EBITDA。
Medline Inc. 预计,其Medline品牌床退出市场所涉及的相关成本在2026年和2027年合计最高可达2.2亿美元,该笔费用将不计入调整后EBITDA。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.